RSVYX Mutual Fund

NAV$27.09

Fund Essentials - as of Mar 31, 2026

Net Assets
$107M
Expense Ratio
1.06%
Dividend Yield (Current)
8.01%
Holdings
58
Inception Date
May 1, 2007
Fund Family
Victory Capital Management Inc.
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually
SEC 30-Day Yield
••••••••••

Performance

YTD+7.24%
1 Year+20.06%
3 Year+12.47%
5 Year+8.99%
10 Year+10.56%

Asset Allocation

Stocks: 98.33%
Bonds: 1.68%

Top Holdings

View All →
TickerNameWeight
GLGlobe Life Inc3.66%
MKTXMarketaxess Holdings Inc3.46%
FEFirstenergy Corp.3.00%
TEVA:ILTeva Pharmaceutical Industries Limited (Adr)2.81%
TKRTimken Co2.76%
Top 10 Concentration: 28.10%Report Date: Mar 31, 2026
Download all 58 holdings for RSVYX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
8.01%
Frequency
Annually
Latest Distribution
$0.17
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

RSVYX Mutual Fund Overview

RSVYX Mutual Fund (Victory RS Value Fund Class Y) is managed by Victory Capital Management Inc. with $106.7M in net assets. RSVYX expense ratio is 1.06%, holding 58 positions across sectors including Industrials, Financials, Information Technology. Inception date: 2007-05-01.

RSVYX performance shows a YTD return of 7.24%. The 1-year return is 20.06% and the 5-year return is 8.99%. RSVYX dividend yield stands at 8.01%, paid annually.

RSVYX top holdings include Globe Life Inc (3.7%), Marketaxess Holdings Inc (3.5%), Firstenergy Corp. (3.0%), Teva Pharmaceutical Industries Limited (Adr) (2.8%), Timken Co (2.8%). View all RSVYX holdings, sector breakdown, or dividend history.

RSVYX can be compared against other funds using the overlap calculator or side-by-side comparison tool. RSVYX alternatives are available via the screener, along with tax-loss harvesting opportunities.